The divestment of Nimenrix and Mencevax was to satisfy regulatory clearances when GSK gained Novartis' vaccines business in an asset swap in March 2015. / read more /
The Latvian government and Pharma have signed a letter of intent on 29 June 2015, agreeing on measures and a mutual cooperation in projects that will help improve medicines access and health outcomes in Latvia. / read more /
The pharmaceutical industry wants to speed up the variations process by eliminating redundant assessment by different national agencies in the European Union. / read more /
In this live webinar, experts will showcase how to formulate a peroxide-sensitive drug using a binder that combines high binding strength with no peroxide formation at all. Sponsored by: BASF
A compilation of articles in a three-handbook set covering general Analytical Testing and Stability in the manufacture, packaging, storing, and testing of formulated products. / Click here /
